Equity

  •  
  •  
  •  
  •  

From dd-mm-yy to dd-mm-yy

1d | 1wk | 1m | 3m | 6m | 1yr
Group:
Company Gain (%) LTP Prev Close 52 Week Range
Fiberweb 17.57 64.58 64.58
320
280.1 295
Charms 6.75 55.89 55.89
320
280.1 295
Fiberweb 17.57 64.58 64.58
320
280.1 295
Charms 6.75 55.89 55.89
320
280.1 295
Fiberweb 17.57 64.58 64.58
320
280.1 295
more >

52 Week Range

Group:
Company High Low
  Rate Date Rate Date
Franklin Pharma 64.58 10/02/11 64.58 10/02/11
Franklin Pharma 64.58 10/02/11 64.58 10/02/11
Franklin Pharma 64.58 10/02/11 64.58 10/02/11
Franklin Pharma 64.58 10/02/11 64.58 10/02/11
Franklin Pharma 64.58 10/02/11 64.58 10/02/11
more >

PE Ratio

Group:
Scrip LTP PE
Franklin Pharma... 64.58 64.58
Franklin Pharma... 64.58 64.58
Franklin Pharma... 64.58 64.58
Franklin Pharma... 64.58 64.58
Franklin Pharma... 64.58 64.58
more >

Volume Topper

1d | 1wk | 1m | 3m | 6m | 1yr
Group:
Company LTP Gain/ Loss Traded
      Vol. Qty.
Franklin Pharma... 64.58 64.58% 64.58 64.58
Reliance Pharma... 55.89 -53.70% 55.89 55.89
Franklin Pharma... 64.58 64.58% 64.58 64.58
Reliance Pharma... 55.89 64.58% 55.89 55.89
Franklin Pharma... 64.58 64.58% 64.58 64.58
Reliance Pharma... 55.89 64.58% 55.89 55.89
more >

Advance Decline Ratio

Group:
Group Advances Decline
Franklin Pharma 64.58 64.58
Franklin Pharma 64.58 64.58
Franklin Pharma 64.58 64.58
Franklin Pharma 64.58 64.58
Franklin Pharma 64.58 64.58
more >

Equity News

09:06am
Feb 11, 2011 Morning Note 23-08-10

Taking into account the overall setup, the index has to record a strong close above its rising trendline resistance with increasing volumes to continue

08:30am
Feb 11, 2011 Early Morning Note 23-08-10

Taking into account the overall setup, the index has to record a strong close above its rising trendline resistance with increasing volumes to continue

more >

Corporate Events

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

more >